1. MichaelisC, CioskR, NasmythK (1997) Cohesins: chromosomal proteins that prevent premature separation of sister chromatids. Cell 91: 35–45.
2. XiongB, GertonJL Regulators of the cohesin network. Annu Rev Biochem 79: 131–153.
3. NasmythK Cohesin: a catenase with separate entry and exit gates? Nat Cell Biol 13: 1170–1177.
4. BeckouetF, HuB, RoigMB, SutaniT, KomataM, et al. An Smc3 acetylation cycle is essential for establishment of sister chromatid cohesion. Mol Cell 39: 689–699.
5. ZhangJ, ShiX, LiY, KimBJ, JiaJ, et al. (2008) Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast. Mol Cell 31: 143–151.
6. LiuJ, KrantzID (2008) Cohesin and human disease. Annu Rev Genomics Hum Genet 9: 303–320.
7. VegaH, WaisfiszQ, GordilloM, SakaiN, YanagiharaI, et al. (2005) Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion. Nat Genet 37: 468–470.
8. FreemanMV, WilliamsDW, SchimkeRN, TemtamySA, VachierE, et al. (1974) The Roberts syndrome. Birth Defects Orig Artic Ser 10: 87–95.
9. FreemanMV, WilliamsDW, SchimkeRN, TemtamySA, VachierE, et al. (1974) The Roberts syndrome. Clin Genet 5: 1–16.
10. GermanJ (1979) Roberts' syndrome. I. Cytological evidence for a disturbance in chromatid pairing. Clin Genet 16: 441–447.
11. TomkinsD, HunterA, RobertsM (1979) Cytogenetic findings in Roberts-SC phocomelia syndrome(s). Am J Med Genet 4: 17–26.
12. Van Den BergDJ, FranckeU (1993) Roberts syndrome: a review of 100 cases and a new rating system for severity. Am J Med Genet 47: 1104–1123.
13. GordilloM, VegaH, TrainerAH, HouF, SakaiN, et al. (2008) The molecular mechanism underlying Roberts syndrome involves loss of ESCO2 acetyltransferase activity. Hum Mol Genet 17: 2172–2180.
14. BoseT, LeeKK, LuS, XuB, HarrisB, et al. Cohesin proteins promote ribosomal RNA production and protein translation in yeast and human cells. PLoS Genet 8: e1002749.
15. GardS, LightW, XiongB, BoseT, McNairnAJ, et al. (2009) Cohesinopathy mutations disrupt the subnuclear organization of chromatin. J Cell Biol 187: 455–462.
16. LindstromMS, DeisenrothC, ZhangY (2007) Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions. Cell Cycle 6: 434–437.
17. FumagalliS, Di CaraA, Neb-GulatiA, NattF, SchwembergerS, et al. (2009) Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 11: 501–508.
18. ZhangY, LuH (2009) Signaling to p53: ribosomal proteins find their way. Cancer Cell 16: 369–377.
19. CoqueretO (2003) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65–70.
20. FumagalliS, IvanenkovVV, TengT, ThomasG Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 26: 1028–1040.
21. DeisenrothC, ZhangY Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 29: 4253–4260.
22. ChakrabortyA, UechiT, HigaS, ToriharaH, KenmochiN (2009) Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS One 4: e4152.
23. OliverER, SaundersTL, TarleSA, GlaserT (2004) Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development 131: 3907–3920.
24. Ferreira-CercaS, HurtE (2009) Cell biology: Arrest by ribosome. Nature 459: 46–47.
25. PanicL, TamarutS, Sticker-JantscheffM, BarkicM, SolterD, et al. (2006) Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol Cell Biol 26: 8880–8891.
26. SchmelzleT, HallMN (2000) TOR, a central controller of cell growth. Cell 103: 253–262.
27. HolzMK, BallifBA, GygiSP, BlenisJ (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123: 569–580.
28. ZoncuR, EfeyanA, SabatiniDM mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21–35.
29. FingarDC, RichardsonCJ, TeeAR, CheathamL, TsouC, et al. (2004) mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24: 200–216.
30. FingarDC, SalamaS, TsouC, HarlowE, BlenisJ (2002) Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16: 1472–1487.
31. HayN, SonenbergN (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926–1945.
32. ChenH, FanM, PfefferLM, LaribeeRN The histone H3 lysine 56 acetylation pathway is regulated by target of rapamycin (TOR) signaling and functions directly in ribosomal RNA biogenesis. Nucleic Acids Res 40: 6534–6546.
33. Vazquez-MartinA, CufiS, Oliveras-FerrarosC, MenendezJA Raptor, a positive regulatory subunit of mTOR complex 1, is a novel phosphoprotein of the rDNA transcription machinery in nucleoli and chromosomal nucleolus organizer regions (NORs). Cell Cycle 10: 3140–3152.
34. ReiterA, SteinbauerR, PhilippiA, GerberJ, TschochnerH, et al. Reduction in ribosomal protein synthesis is sufficient to explain major effects on ribosome production after short-term TOR inactivation in Saccharomyces cerevisiae. Mol Cell Biol 31: 803–817.
35. DickinsonJM, RasmussenBB Essential amino acid sensing, signaling, and transport in the regulation of human muscle protein metabolism. Curr Opin Clin Nutr Metab Care 14: 83–88.
36. NicklinP, BergmanP, ZhangB, TriantafellowE, WangH, et al. (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136: 521–534.
37. NobukuniT, JoaquinM, RoccioM, DannSG, KimSY, et al. (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A 102: 14238–14243.
38. BonfilsG, JaquenoudM, BontronS, OstrowiczC, UngermannC, et al. (2012) Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol Cell 46: 105–110.
39. HanJM, JeongSJ, ParkMC, KimG, KwonNH, et al. (2012) Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149: 410–424.
40. GertonJL (2012) Translational mechanisms at work in the cohesinopathies. Nucleus 3: 520–525.
41. van der LelijP, GodthelpBC, van ZonW, van GosligaD, OostraAB, et al. (2009) The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2. PLoS One 4: e6936.
42. MonnichM, KurigerZ, PrintCG, HorsfieldJA A zebrafish model of Roberts syndrome reveals that Esco2 depletion interferes with development by disrupting the cell cycle. PLoS One 6: e20051.
43. KomarovPG, KomarovaEA, KondratovRV, Christov-TselkovK, CoonJS, et al. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733–1737.
44. GaryRK, JensenDA (2005) The p53 inhibitor pifithrin-alpha forms a sparingly soluble derivative via intramolecular cyclization under physiological conditions. Mol Pharm 2: 462–474.
45. BarlowJL, DrynanLF, HewettDR, HolmesLR, Lorenzo-AbaldeS, et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 16: 59–66.
46. RiekerC, EngblomD, KreinerG, DomanskyiA, SchoberA, et al. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling. J Neurosci 31: 453–460.
47. ParlatoR, KreinerG, ErdmannG, RiekerC, StotzS, et al. (2008) Activation of an endogenous suicide response after perturbation of rRNA synthesis leads to neurodegeneration in mice. J Neurosci 28: 12759–12764.
48. PietrzakM, RempalaG, NelsonPT, ZhengJJ, HetmanM Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease. PLoS One 6: e22585.
49. LuS, GoeringM, GardS, XiongB, McNairnAJ, et al. (2010) Eco1 is important for DNA damage repair in S. cerevisiae. Cell Cycle 9: 3315–3327.
50. DennisPB, PullenN, KozmaSC, ThomasG (1996) The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol 16: 6242–6251.
51. von ManteuffelSR, DennisPB, PullenN, GingrasAC, SonenbergN, et al. (1997) The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol Cell Biol 17: 5426–5436.
52. ChiangGG, AbrahamRT (2005) Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem 280: 25485–25490.
53. NaveBT, OuwensM, WithersDJ, AlessiDR, ShepherdPR (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344 Pt 2: 427–431.
54. SekulicA, HudsonCC, HommeJL, YinP, OtternessDM, et al. (2000) A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60: 3504–3513.
55. AlexanderA, CaiSL, KimJ, NanezA, SahinM, et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107: 4153–4158.
56. NortonLE, LaymanDK (2006) Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. J Nutr 136: 533S–537S.
57. KimballSR, ShantzLM, HoretskyRL, JeffersonLS (1999) Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem 274: 11647–11652.
58. AnthonyJC, YoshizawaF, AnthonyTG, VaryTC, JeffersonLS, et al. (2000) Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130: 2413–2419.
59. PeyrollierK, HajduchE, BlairAS, HydeR, HundalHS (2000) L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport. Biochem J 350 Pt 2: 361–368.
60. ChenL, XuB, LiuL, LuoY, YinJ, et al. Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Lab Invest 90: 762–773.
61. StockerH, RadimerskiT, SchindelholzB, WittwerF, BelawatP, et al. (2003) Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol 5: 559–565.
62. ZhangY, GaoX, SaucedoLJ, RuB, EdgarBA, et al. (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5: 578–581.
63. GaramiA, ZwartkruisFJ, NobukuniT, JoaquinM, RoccioM, et al. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457–1466.
64. InokiK, LiY, XuT, GuanKL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829–1834.
65. TeeAR, ManningBD, RouxPP, CantleyLC, BlenisJ (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13: 1259–1268.
66. ManningBD, CantleyLC (2003) Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 28: 573–576.
67. WullschlegerS, LoewithR, HallMN (2006) TOR signaling in growth and metabolism. Cell 124: 471–484.
68. FengZ, ZhangH, LevineAJ, JinS (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A 102: 8204–8209.
69. BudanovAV, KarinM (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451–460.
70. HosoiH, DillingMB, ShikataT, LiuLN, ShuL, et al. (1999) Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res 59: 886–894.
71. TsangCK, LiuH, ZhengXF mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes. Cell Cycle 9: 953–957.
72. WinderWW (2001) Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 91: 1017–1028.
73. TerretME, SherwoodR, RahmanS, QinJ, JallepalliPV (2009) Cohesin acetylation speeds the replication fork. Nature 462: 231–234.
74. KangMA, SoEY, SimonsAL, SpitzDR, OuchiT DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. Cell Death Dis 3: e249.
75. VafaO, WadeM, KernS, BeecheM, PanditaTK, et al. (2002) c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031–1044.
76. MarchettiMA, WeinbergerM, MurakamiY, BurhansWC, HubermanJA (2006) Production of reactive oxygen species in response to replication stress and inappropriate mitosis in fission yeast. J Cell Sci 119: 124–131.
77. AmsterdamA, NissenRM, SunZ, SwindellEC, FarringtonS, et al. (2004) Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A 101: 12792–12797.
78. RooryckC, Diaz-FontA, OsbornDP, ChabchoubE, Hernandez-HernandezV, et al. Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat Genet 43: 197–203.
79. RokutandaS, FujitaT, KanataniN, YoshidaCA, KomoriH, et al. (2009) Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev Biol 328: 78–93.
80. PengXD, XuPZ, ChenML, Hahn-WindgassenA, SkeenJ, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352–1365.
81. WhelanG, KreidlE, WutzG, EgnerA, PetersJM, et al. Cohesin acetyltransferase Esco2 is a cell viability factor and is required for cohesion in pericentric heterochromatin. Embo J 31: 71–82.
82. RhodesJM, BentleyFK, PrintCG, DorsettD, MisulovinZ, et al. Positive regulation of c-Myc by cohesin is direct, and evolutionarily conserved. Dev Biol 344: 637–649.
83. MutoA, CalofAL, LanderAD, SchillingTF Multifactorial origins of heart and gut defects in nipbl-deficient zebrafish, a model of Cornelia de Lange Syndrome. PLoS Biol 9: e1001181.
84. GhiselliG (2006) SMC3 knockdown triggers genomic instability and p53-dependent apoptosis in human and zebrafish cells. Mol Cancer 5: 52.
85. DeardorffMA, KaurM, YaegerD, RampuriaA, KorolevS, et al. (2007) Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation. Am J Hum Genet 80: 485–494.
86. DeardorffMA, WildeJJ, AlbrechtM, DickinsonE, TennstedtS, et al. RAD21 mutations cause a human cohesinopathy. Am J Hum Genet 90: 1014–1027.
87. BoseT, LeeKK, LuS, XuB, HarrisB, et al. (2012) Cohesin proteins promote ribosomal RNA production and protein translation in yeast and human cells. PLoS Genet 8: e1002749.
88. KawauchiS, CalofAL, SantosR, Lopez-BurksME, YoungCM, et al. (2009) Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/−) mouse, a model of Cornelia de Lange Syndrome. PLoS Genet 5: e1000650.
89. MutoA, CalofAL, LanderAD, SchillingTF (2011) Multifactorial Origins of Heart and Gut Defects in nipbl-Deficient Zebrafish, a Model of Cornelia de Lange Syndrome. PLoS Biol 9: e1001181.
90. CarnevalliLS, MasudaK, FrigerioF, Le BacquerO, UmSH, et al. S6K1 plays a critical role in early adipocyte differentiation. Dev Cell 18: 763–774.
91. RubioED, ReissDJ, WelcshPL, DistecheCM, FilippovaGN, et al. (2008) CTCF physically links cohesin to chromatin. Proc Natl Acad Sci U S A 105: 8309–8314.
92. McEwanMV, EcclesMR, HorsfieldJA Cohesin is required for activation of MYC by estradiol. PLoS One 7: e49160.
93. StedmanW, KangH, LinS, KissilJL, BartolomeiMS, et al. (2008) Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. Embo J 27: 654–666.
94. FilippovaGN, FagerlieS, KlenovaEM, MyersC, DehnerY, et al. (1996) An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol 16: 2802–2813.
95. GimiglianoA, ManniniL, BianchiL, PugliaM, DeardorffMA, et al. Proteomic profile identifies dysregulated pathways in Cornelia de Lange syndrome cells with distinct mutations in SMC1A and SMC3 genes. J Proteome Res 11: 6111–6123.
96. RemeseiroS, CuadradoA, Gomez-LopezG, PisanoDG, LosadaA A unique role of cohesin-SA1 in gene regulation and development. Embo J 31: 2090–2102.
97. van RiggelenJ, YetilA, FelsherDW MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 10: 301–309.
98. DauwerseJG, DixonJ, SelandS, RuivenkampCA, van HaeringenA, et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 43: 20–22.
99. PellagattiA, Hellstrom-LindbergE, GiagounidisA, PerryJ, MalcovatiL, et al. (2008) Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol 142: 57–64.
100. ChoesmelV, BacquevilleD, RouquetteJ, Noaillac-DepeyreJ, FribourgS, et al. (2007) Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 109: 1275–1283.
101. BoocockGR, MorrisonJA, PopovicM, RichardsN, EllisL, et al. (2003) Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 33: 97–101.
102. PereboomTC, van WeeleLJ, BondtA, MacInnesAW A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization. Blood 118: 5458–5465.
103. FumagalliS, ThomasG The role of p53 in ribosomopathies. Semin Hematol 48: 97–105.
104. NarlaA, EbertBL Ribosomopathies: human disorders of ribosome dysfunction. Blood 115: 3196–3205.
105. YuanX, ZhouY, CasanovaE, ChaiM, KissE, et al. (2005) Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell 19: 77–87.
106. JonesNC, LynnML, GaudenzK, SakaiD, AotoK, et al. (2008) Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med 14: 125–133.
107. McGowanKA, PangWW, BhardwajR, PerezMG, PluvinageJV, et al. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood 118: 3622–3633.
108. McGowanKA, LiJZ, ParkCY, BeaudryV, TaborHK, et al. (2008) Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40: 963–970.
109. ToriharaH, UechiT, ChakrabortyA, ShinyaM, SakaiN, et al. (2011) Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia. Br J Haematol 152: 648–654.
110. ProvostE, WehnerKA, ZhongX, AsharF, NguyenE, et al. (2012) Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development. Development 139: 3232–3241.
111. PayneEM, VirgilioM, NarlaA, SunH, LevineM, et al. L-leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 120: 2214–2224.
112. JaakoP, DebnathS, OlssonK, BryderD, FlygareJ, et al. Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. Blood 120: 2225–2228.
113. KimmelCB, BallardWW, KimmelSR, UllmannB, SchillingTF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253–310.
114. ZhangY, SikesML, BeyerAL, SchneiderDA (2009) The Paf1 complex is required for efficient transcription elongation by RNA polymerase I. Proc Natl Acad Sci U S A 106: 2153–2158.
115. JonesRG, PlasDR, KubekS, BuzzaiM, MuJ, et al. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283–293.
116. OkoshiR, OzakiT, YamamotoH, AndoK, KoidaN, et al. (2008) Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol Chem 283: 3979–3987.